Three zanamivir copies clump the particles
The chemists clicked a single copy, a pair, or a trio of the same flu drug onto the Fc fragment of an antibody. Zanamivir was the first drug in that series. The three-copy form, called AVC-Z3, was more active in cells than the one-copy and two-copy forms. AVC-Z3 drew separate virus particles into clusters. Clustered particles were poorer at entering a cell and poorer at leaving one afterwards.[1]
The clump is a physical hold, set beside the drug’s ordinary action on neuraminidase. The authors treat the copy count as the feature that changes how the molecule behaves. CD388, an earlier long-acting drug-Fc conjugate aimed at influenza A and influenza B, is the molecule they measure the new series against.[1]
